Akers Biosciences Inc. [NASDAQ: AKER] loss -9.46% on the last trading session, reaching $3.35 price per share at the time. Akers Biosciences Inc. represents 2.23 million in outstanding shares, while the company has a total market value of $21.00 million with the latest information. AKER stock price has been found in the range of $3.30 to $3.78.
If compared to the average trading volume of 2.55M shares, AKER reached a trading volume of 1144744 in the most recent trading day, which is why market watchdogs consider the stock to be active.
3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Here is what top equities market gurus are saying about Akers Biosciences Inc. [AKER]:
The Average True Range (ATR) for Akers Biosciences Inc. is set at 0.33, with the Price to Sales ratio for AKER stock in the period of the last 12 months amounting to 16.16. The Price to Book ratio for the last quarter was 1.17, with the Price to Cash per share for the same quarter was set at 1.18.
Trading performance analysis for AKER stock
Akers Biosciences Inc. [AKER] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -8.97. With this latest performance, AKER shares dropped by -8.22% in over the last four-week period, additionally plugging by 12.79% over the last 6 months – not to mention a drop of -75.93% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for AKER stock in for the last two-week period is set at 40.34, with the RSI for the last a single of trading hit 40.34, and the three-weeks RSI is set at 47.25 for Akers Biosciences Inc. [AKER]. The present Moving Average for the last 50 days of trading for this stock 3.66, while it was recorded at 3.63 for the last single week of trading, and 5.40 for the last 200 days.
Akers Biosciences Inc. [AKER]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Akers Biosciences Inc. [AKER] shares currently have an operating margin of -241.25 and a Gross Margin at +27.82. Akers Biosciences Inc.’s Net Margin is presently recorded at -246.55.
Return on Total Capital for AKER is now -50.10, given the latest momentum, and Return on Invested Capital for the company is -51.20. Return on Equity for this stock declined to -51.20, with Return on Assets sitting at -41.60.
Reflecting on the efficiency of the workforce at the company, Akers Biosciences Inc. [AKER] managed to generate an average of -$324,021 per employee. Receivables Turnover for the company is 14.39 with a Total Asset Turnover recorded at a value of 0.17.Akers Biosciences Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 3.70 and a Current Ratio set at 3.80.
An analysis of insider ownership at Akers Biosciences Inc. [AKER]
There are presently around $1 million, or 10.70% of AKER stock, in the hands of institutional investors. The top three institutional holders of AKER stocks are: HUDSON BAY CAPITAL MANAGEMENT LP with ownership of 240,305, which is approximately -10.748% of the company’s market cap and around 0.30% of the total institutional ownership; SABBY MANAGEMENT, LLC, holding 55,400 shares of the stock with an approximate value of $0.2 million in AKER stocks shares; and RENAISSANCE TECHNOLOGIES LLC, currently with $0.15 million in AKER stock with ownership of nearly New of the company’s market capitalization.
Positions in Akers Biosciences Inc. stocks held by institutional investors increased at the end of May and at the time of the May reporting period, where 8 institutional holders increased their position in Akers Biosciences Inc. [NASDAQ:AKER] by around 81,445 shares. Additionally, 6 investors decreased positions by around 140,640 shares, while 6 investors held positions by with 152,213 shares. The mentioned changes placed institutional holdings at 374,298 shares, according to the latest SEC report filing. AKER stock had 6 new institutional investments in for a total of 54,624 shares, while 4 institutional investors sold positions of 111,681 shares during the same period.